Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China flag China · Delayed Price · Currency is CNY
15.24
-0.59 (-3.73%)
Jul 30, 2026, 9:25 AM CST

SHA:600513 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,8952,7122,1602,1741,9551,646
Revenue Growth
28.10%25.52%-0.63%11.20%18.80%18.74%
Gross Profit
887.29932.771,0621,0441,043896.95
Operating Income
-11.619.01124.81179.96202.84171.52
Net Income
-114.97-98.3384.16135.01141.37118.84
Earnings Per Share
-0.39-0.340.290.470.490.41
EPS Growth
---38.30%-4.08%19.51%13.89%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Pharmaceutical Manufacturing
1,096
Medicine Circulation
1,602
Total
2,698

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
265.5349.09227.72281.38330.65330.69
Total Debt
1,6091,550883.33705.78689.69558.63
Net Cash (Debt)
-1,344-1,201-655.61-424.4-359.05-227.93
Net Cash Growth
------
Net Cash Per Share
-4.52-4.15-2.26-1.48-1.24-0.79

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-40.33-14.4710.77160.7127.59138.34
Capital Expenditures
-249.89-271.4-184.85-200.67-220.68-172.11
Free Cash Flow
-290.22-285.87-174.08-39.96-93.09-33.77
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
30.65%34.40%49.13%48.02%53.32%54.50%
Operating Margin
-0.40%0.70%5.78%8.28%10.37%10.42%
Pretax Margin
-4.09%-3.23%6.04%8.05%9.67%9.70%
Profit Margin
-3.97%-3.63%3.90%6.21%7.23%7.22%
FCF Margin
-10.03%-10.54%-8.06%-1.84%-4.76%-2.05%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0700.0700.0890.1500.1500.125
Dividend Per Share Growth
-21.35%-21.35%-40.67%0%20.00%15.74%
Dividend Yield
0.44%0.38%0.91%1.39%1.67%1.37%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--33.6123.5519.0723.41
PS Ratio
1.501.931.311.461.381.69